Patent Assignment
Reel/Frame 073164/0032
Patent Security Agreement
Recorded: 2025-10-20
Pages: 20
Assignors
VALNEVA AUSTRIA GMBH
Executed: 2025-10-17
VALNEVA SE
Executed: 2025-10-17
VALNEVA SWEDEN AB
Executed: 2025-10-17
Assignee
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties
(67)
Methods and Compositions Involving Immunostimulatory Oligodeoxynucleotides
Vaccine Composition Comprising an Antigen and a Peptide Having Adjuvant Properties
Vaccines
Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines
A Method of Obtaining Chicken Embryonic Stem Cells
Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines
Aluminum Compounds for Use in Therapeutics and Vaccines
MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines
Aluminum Compounds for Use in Therapeutics and Vaccines
Method of Making a Virus Using Duck Embryonic Derived Stem Cell Lines
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Aluminum Compounds for Use in Therapeutics and Vaccines
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
Aseptic Purification Process for Viruses
Zika Virus Purification
Virus Purification
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Zika Virus Purification
Virus Purification
Zika Virus Vaccine
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Multivalent Ospa Polypeptides and Methods and Uses Relating Thereto
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Virus Purification
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Aluminum Compounds for Use in Therapeutics and Vaccines
Zika Virus Vaccine
Aseptic Purification Process for Viruses
Virus Purification
Zika Virus Purification
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Method for Rescuing and Producing a Virus in Avian Cells
Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NP3
CpG-ADJUVANTED SARS-CoV-2 VIRUS VACCINE
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Zika Virus Vaccine
Chikungunya Vaccine Formulations
Application:
17/632,943 →
Publication:
US 2022/0288185
Single Shot Chikungunya Virus Vaccine
Application:
17/632,946 →
Publication:
US 2022/0313810
Inactivation Process for Viruses
Application:
17/688,960 →
Publication:
US 2022/0298493
Coronavirus Vaccines Comprising a TLR9 Agonist
Application:
17/802,361 →
Publication:
US 2023/0092650
Virus Purification
Improvements in Vaccine Formulations for Medical Use
Application:
17/917,010 →
Publication:
US 2023/0398210
Improved Methods of Producing a Lipidated Protein
Application:
17/917,016 →
Publication:
US 2024/0026412
Compositions Comprising Three Ospa Fusion Proteins for Medical Use
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application:
17/932,226 →
Publication:
US 2023/0295245
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Cholera Vaccine Formulation
Application:
18/027,657 →
Publication:
US 2023/0372464
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
Application:
18/150,971 →
Publication:
US 2023/0322869
Zika Virus Vaccine
Zika Virus Vaccine
Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus Chikv-DELTA5NSP3
Multivalent Ospa Polypeptides and Methods and Uses Relating Thereto
Zika Virus Vaccine
Application:
18/799,291 →
Publication:
US 2025/0018023
Clostridium Difficile Vaccine
Application:
18/867,201 →
Publication:
US 2025/0213667
Process for Virus Production in a Bioreactor
Application:
19/147,841 →
Immunogenic Chikungunya Compositions for Administration to Immunocompromised Patients
Application:
19/162,120 →
Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Application:
19/202,001 →
Publication:
US 2025/0360191
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 17, 2003
From: FRITZ, JORG; MATTNER, FRANK; ZAUNER, WOLFGANG; NAGY, ESZTER
To: INTERCELL BIOMEDIZINISCHE FORSCHUNGS-UND ENTWICKLUNGS AG
Reel/Frame 014400/0764 →
Change of Name
Feb 9, 2007
From: INTERCELL BIOMEDIZINISCHE FORSCHUNGS-UND ENTWICKLUNGS AG
To: INTERCELL AG
Reel/Frame 018876/0637 →
Assignment of Assignor's Interest
Mar 29, 2007
From: BUSCHLE, MICHAEL; HABEL, ANDRE; FRITZ, JORG; PRINZ, KARIN
To: INTERCELL AG
Reel/Frame 019085/0711 →
Assignment of Assignor's Interest
Jan 14, 2009
From: MEHTALI, MAJID; CHAMPION-ARNAUD, PATRICK; LEON, ARNAUD
To: VIVALIS
Reel/Frame 022106/0677 →
Assignment of Assignor's Interest
Apr 21, 2010
From: VALARCHE, ISABELLE; BATARD, LUC; MEHTALI, MAJID
To: VIVALIS
Reel/Frame 024264/0067 →
Assignment of Assignor's Interest
Jun 12, 2012
From: SCHLEGL, ROBERT; MOHLEN, MICHAEL; WRUSS, JURGEN; WEBER, MICHAEL
To: INTERCELL AG
Reel/Frame 028358/0972 →
Assignment of Assignor's Interest
Jun 4, 2013
From: COMSTEDT, PAR; HANNER, MARKUS; LUNDBERG, URBAN; MEINKE, ANDREAS
To: INTERCELL AG
Reel/Frame 030541/0775 →
Asset Transfer Agreement
Jun 13, 2013
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 030610/0627 →
Asset Transfer Agreement
Sep 25, 2013
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 031283/0233 →
Change of Name
Sep 25, 2013
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 031283/0473 →
Change of Name
Jan 24, 2014
From: VIVALIS
To: VALNEVA
Reel/Frame 032036/0864 →
Change of Name
Mar 21, 2014
From: VIVALIS
To: VALNEVA
Reel/Frame 032497/0739 →
Asset Transfer Agreement
Apr 10, 2014
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 032651/0786 →
Change of Name
Apr 10, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 032642/0164 →
Assignment of Assignor's Interest
Sep 9, 2014
From: GUEHENNEUX, FABIENNE
To: VALNEVA
Reel/Frame 033697/0396 →
Change of Name
Sep 26, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 033824/0026 →
Assignment of Assignor's Interest
Oct 30, 2014
From: WESTRITSCHNIG, KERSTIN
To: VALNEVA AUSTRIA GMBH
Reel/Frame 034067/0290 →
Assignment of Assignor's Interest
Oct 30, 2014
From: ELLINGSWORTH, LARRY R.; FLYER, DAVID; TIAN, JING-HUI; FUHRMANN, STEVEN R.
To: INTERCELL USA, INC.
Reel/Frame 034067/0261 →
Asset Transfer Agreement
Dec 17, 2014
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 034659/0640 →
Change of Name
Dec 17, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 034524/0311 →
Change of Name
May 18, 2016
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 038636/0555 →
Assignment of Assignor's Interest
May 18, 2016
From: SCHLEGL, ROBERT; MOHLEN, MICHAEL; WRUSS, JURGEN; WEBER, MICHAEL
To: INTERCELL AG
Reel/Frame 038746/0225 →
Asset Transfer Agreement
May 18, 2016
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 038746/0240 →
Change of Name
Aug 22, 2016
From: VIVALIS SA
To: VALNEVA
Reel/Frame 039498/0958 →
Assignment of Assignor's Interest
Aug 22, 2016
From: SCHLEGL, ROBERT; MOHLEN, MICHAEL; WRUSS, JURGEN; WEBER, MICHAEL
To: INTERCELL AG
Reel/Frame 039771/0993 →